Colorado: Mandatory Pesticide Testing begins August 1, 2018
Mandatory pesticide testing for both medical and recreational marijuana flower and trim begins Wednesday, August 1, 2018 in Colorado. All harvest batches created on or after August 1, will require pesticide testing from all medical and recreational cultivation facilities. Pesticide testing for concentrates is not required.
Which Pesticides?
The permitted pesticides tested are listed in Rule R 712(E)(5), and include, but are not limited to: Abamectin (Avermectins: B1a & B1b), Azoxystrobin, Bifenazate, Etoxazole, Imazalil, Imidacloprid, Malathion, Myclobutanil, Permethrin (mix of isomers), Spinosad (Mixture of A and D), Spiromesifen, Spirotetramat, and Tebuconazole. However, if a permitted pesticide is applied improperly, a harvest batch can fail a test. Harvest batches detected with other banned pesticides not specifically listed in MED rules may also fail pesticide testing.
What Happens if a Harvest Batch Fails One of the Pesticide Tests?
If a harvest batch fails one or more pesticide tests, there is a procedure to retest the original test batch. The licensee must request that two additional samples that be retested for the failed pesticide. If one or both retests give a result above the allowable PPM level, all batches associated with this Harvest Batch must be destroyed.
Don’t Make an Expensive Mistake!
The use of chemicals is part of modern agriculture. Maintaining healthy marijuana plants and indoor grow environments is a challenge under a commercial production schedule. It is essential to comply with new pesticide testing regulation. A non-compliant harvest batch may not only be an expensive mistake, it can be a public health fiasco for a marijuana business to be associated with high levels of pesticides and failed tests. The attorneys at McAllister Garfield, P.C. are available to answer client questions on this new testing regulation.
Click below to read MED Bulletin 18-07.
https://www.colorado.gov/pacific/sites/default/files/IB%2018-07%20Pesticide%20IB%2006292018.pdf
Related Article
Emerging Trends In Psychedelic Laws: Implications for Practitioners
As the psychedelic renaissance continues, legal landscapes globally are evolving rapidly. What was once a fringe area of medical research and therapy is now moving towards mainstream acceptance, driven by promising results in clinical trials and changing public perceptions. For practitioners, these shifts present both exciting opportunities and complex challenges. This blog post explores emerging […]
McAllister Law Office – Psychedelic Law Update – June 2024
1. With Sean McAllister as one of their lawyers, The Church of The Eagle and The Condor is recognized as the third religious organization authorized to use ayahuasca in the United States. In a career highlight, I was honored to one of five lawyers representing The Church of The Eagle and The Condor (“CEC”) in […]
Navigating New Realms: The Crucial Role Of Legal Guidance In Psychedelic Business Start-Ups
In recent years, the interest in psychedelics for therapeutic purposes has surged, offering a promising frontier in both medical science and entrepreneurship. However, the burgeoning field of psychedelic businesses also presents a unique set of legal challenges. For start-ups in this industry, navigating the complex regulatory environment is not just about compliance, but also about […]